Literature DB >> 16440421

Crohn's disease in Stockholm County during 1990-2001: an epidemiological update.

Annika Lapidus1.   

Abstract

AIM: To further assess of the incidence and localization of Crohn's disease (CD) in a well-defined population during the 1990s and to evaluate the prevalence of CD on the 1st of January 2002.
METHODS: In a retrospective population based study, all 16-90 years old citizens of Stockholm County diagnosed as having CD according to Lennard Jones' criteria between 1990 and 2001 were included. Case identification was made by using computerized inpatient and outpatient registers. Moreover private gastroenterologists were asked for possible cases. The extent of the disease and the frequency of anorectal fistulae were determined as were the ages at diagnosis. Further, the prevalence of CD on the 1(st) of January 2002 was assessed.
RESULTS: All the 1 389 patients, 689 men and 700 women, fulfilled the criteria for CD. The mean incidence rate for the whole period was 8.3 per 10(5) (95%CI 7.9 -8.8). There was no difference between the genders. The mean annual incidence of the whole study period for colorectal disease and ileocecal disease, was 4.4 (95%CI 4.0-4.7) and 2.4 (95%CI 2.1-2.6) per 10(5), respectively. Perianal disease occurred in 13.7% (95%CI 11.9-15.7 %) of the patients. The prevalence of CD was 213 per 100,000 inhabitants.
CONCLUSION: The incidence of CD has markedly increased during the last decade in Stockholm County and 0.2% of the population suffers from CD. The increase is attributed to a further increase of colorectal disease, while the incidence of ileocecal disease has remained stable.

Entities:  

Mesh:

Year:  2006        PMID: 16440421      PMCID: PMC4077499          DOI: 10.3748/wjg.v12.i1.75

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Authors:  F L Wolters; M G V M Russel; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

2.  Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence.

Authors:  P Munkholm; E Langholz; O H Nielsen; S Kreiner; V Binder
Journal:  Scand J Gastroenterol       Date:  1992-07       Impact factor: 2.423

3.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

Review 4.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

5.  Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update.

Authors:  G A Thomas; D Millar-Jones; J Rhodes; G M Roberts; G T Williams; J F Mayberry
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-05       Impact factor: 2.566

6.  Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review.

Authors:  J Kyle
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

7.  Smoking in Crohn's disease: effect on localisation and clinical course.

Authors:  E Lindberg; G Järnerot; B Huitfeldt
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

Review 8.  Crohn's disease in the over-60 age group: a population based study.

Authors:  Denis Heresbach; Jean-Luc Alexandre; Jean-François Bretagne; Etienne Cruchant; Alain Dabadie; Michèle Dartois-Hoguin; Pierre-Marie Girardot; Hervé Jouanolle; Jean Kerneis; Jean-Claude Le Verger; Véronnique Louvain; Lena Pennognon; Martial Richecoeur; Joseph Politis; Michel Robaszkiewicz; Jacques Arnaud Seyrig; Isabelle Tron
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 2.566

9.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

10.  The incidence of Crohn's disease is not decreasing in Sweden.

Authors:  E Lindberg; G Jörnerot
Journal:  Scand J Gastroenterol       Date:  1991-05       Impact factor: 2.423

View more
  39 in total

1.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 2.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

3.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 4.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 5.  Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

Authors:  Irene Modesto; Giovanni Perricone; Ambrogio Orlando; Mario Cottone
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Temporal Change in Phenotypic Behaviour in Patients with Crohn's Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients?

Authors:  Rishikesh Kalaria; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Sudeep Shah
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

7.  Infliximab paediatric Crohn's disease educational plan: a European, cross-sectional, multicentre evaluation.

Authors:  Alejandro Arana; Sam Allen; Jörg Burkowitz; Valerio Fantoni; Ola Ghatnekar; María Teresa Rico; Nathalie Vanhaverbeke; Charles E Wentworth; Max Brosa; Felix M Arellano
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.

Authors:  Annelie Lindberg; Michael Eberhardson; Mats Karlsson; Per Karlén
Journal:  BMC Gastroenterol       Date:  2010-07-06       Impact factor: 3.067

10.  Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario.

Authors:  John Hermon-Taylor
Journal:  Gut Pathog       Date:  2009-07-14       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.